This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
adjective | noun | frequency |
---|---|---|
covid-19 | patients | 6479 |
- | cell | 3577 |
- | analysis | 3072 |
covid-19 | infection | 2787 |
- | risk | 2775 |
high | risk | 2529 |
- | time | 2360 |
- | hospital | 2202 |
- | care | 1495 |
higher | risk | 1440 |
pulmonary | disease | 1407 |
viral | infections | 1405 |
clinical | outcomes | 1331 |
severe | disease | 1319 |
viral | infection | 1289 |
patient | care | 1284 |
- | cells | 1126 |
severe | cases | 1036 |
clinical | data | 1017 |
- | patient | 843 |
respiratory | rate | 838 |
high | levels | 811 |
positive | patients | 790 |
clinical | outcome | 761 |
other | patients | 753 |
- | year | 752 |
respiratory | infections | 733 |
covid-19 | cases | 731 |
- | level | 726 |
clinical | studies | 720 |
respiratory | disease | 720 |
older | patients | 693 |
severe | covid-19 | 687 |
respiratory | infection | 670 |
- | infection | 665 |
- | treatment | 664 |
severe | patients | 649 |
first | time | 627 |
medical | care | 585 |
other | studies | 563 |
older | age | 555 |
higher | levels | 548 |
first | case | 548 |
patients | aged | 519 |
low | risk | 512 |
such | patients | 509 |
- | group | 490 |
patient | outcomes | 487 |
high | level | 474 |
positive | results | 450 |
acute | care | 442 |
- | patients | 434 |
- | day | 424 |
first | year | 391 |
chronic | diseases | 389 |
high | rate | 388 |
medical | treatment | 374 |
other | factors | 373 |
low | levels | 359 |
higher | rate | 350 |
chronic | disease | 348 |
more | patients | 346 |
covid-19 | patient | 344 |
- | analyses | 341 |
higher | rates | 334 |
patient | age | 328 |
patient | groups | 326 |
respiratory | diseases | 324 |
clinical | study | 318 |
patient | group | 310 |
significant | risk | 308 |
clinical | care | 305 |
negative | patients | 304 |
negative | results | 297 |
- | sars | 297 |
- | effects | 282 |
severe | infection | 282 |
lower | risk | 272 |
high | rates | 268 |
covid-19 | disease | 265 |
pulmonary | infection | 263 |
first | day | 260 |
severe | infections | 260 |
patient | data | 258 |
early | treatment | 253 |
positive | cells | 246 |
- | case | 244 |
severe | sars | 244 |
such | cases | 243 |
important | factor | 242 |
medical | therapy | 239 |
first | study | 231 |
other | diseases | 225 |
lower | levels | 225 |
positive | blood | 224 |
other | groups | 219 |
positive | result | 215 |
low | level | 214 |
positive | cases | 212 |
higher | level | 211 |
medical | patients | 211 |
first | group | 209 |
specific | treatment | 209 |
significant | effect | 204 |
new | cases | 203 |
highest | risk | 199 |
first | patient | 198 |
other | patient | 191 |
patient | outcome | 190 |
- | days | 183 |
other | hospitals | 180 |
different | levels | 179 |
- | blood | 174 |
different | time | 173 |
- | years | 173 |
high | blood | 171 |
new | patients | 171 |
old | patient | 171 |
severe | group | 171 |
covid-19 | infections | 170 |
positive | rate | 169 |
pulmonary | infections | 169 |
normal | levels | 164 |
old | age | 158 |
- | therapy | 158 |
acute | infection | 157 |
important | risk | 157 |
- | study | 156 |
different | groups | 154 |
other | risk | 150 |
new | method | 149 |
other | cases | 148 |
human | infection | 145 |
positive | effect | 144 |
- | p | 141 |
different | methods | 140 |
human | disease | 138 |
low | rate | 133 |
negative | result | 133 |
- | infections | 132 |
clinical | disease | 132 |
clinical | case | 129 |
- | effect | 126 |
human | cells | 126 |
lower | rate | 122 |
other | infections | 120 |
more | time | 119 |
- | disease | 119 |
clinical | factors | 118 |
positive | patient | 115 |
positive | sars | 114 |
new | treatment | 113 |
clinical | results | 111 |
covid-19 | outcomes | 111 |
patients | studied | 108 |
pulmonary | diseases | 107 |
important | factors | 107 |
- | factor | 104 |
covid-19 | treatment | 103 |
human | blood | 103 |
lower | rates | 103 |
clinical | cases | 101 |
human | studies | 101 |
clinical | risk | 100 |
viral | disease | 100 |
other | methods | 99 |
other | treatments | 98 |
- | rate | 97 |
severe | outcomes | 96 |
- | age | 92 |
clinical | effects | 92 |
first | days | 92 |
chronic | infection | 90 |
different | studies | 90 |
highest | level | 90 |
specific | therapy | 90 |
first | cases | 89 |
different | cell | 89 |
clinical | treatment | 88 |
more | studies | 88 |
other | therapies | 88 |
positive | effects | 88 |
different | age | 87 |
negative | effects | 87 |
more | data | 86 |
new | disease | 85 |
low | blood | 85 |
early | studies | 85 |
normal | blood | 84 |
other | treatment | 83 |
different | treatment | 82 |
negative | blood | 82 |
new | therapies | 82 |
patient | days | 82 |
viral | diseases | 82 |
first | results | 81 |
- | groups | 80 |
other | day | 79 |
patient | blood | 79 |
lower | level | 78 |
negative | effect | 76 |
patient | treatment | 75 |
early | disease | 74 |
old | patients | 74 |
more | days | 73 |
specific | patient | 73 |
different | patients | 72 |
patient | risk | 71 |
pulmonary | blood | 71 |
common | risk | 70 |
more | cases | 70 |
new | patient | 70 |
new | data | 69 |
acute | infections | 67 |
other | group | 67 |
significant | factor | 67 |
other | cells | 66 |
human | cell | 66 |
negative | rate | 65 |
different | times | 64 |
such | studies | 64 |
- | methods | 63 |
different | patient | 63 |
positive | group | 63 |
earlier | studies | 62 |
other | disease | 62 |
other | study | 61 |
different | blood | 60 |
specific | risk | 60 |
other | blood | 60 |
human | cases | 59 |
specific | factors | 59 |
- | levels | 58 |
different | disease | 56 |
negative | cases | 56 |
negative | group | 56 |
patients | age | 55 |
such | infections | 55 |
significant | factors | 55 |
significant | effects | 55 |
- | method | 55 |
patient | factors | 55 |
common | disease | 55 |
clinical | effect | 55 |
respiratory | therapy | 54 |
specific | cell | 54 |
specific | therapies | 54 |
normal | level | 54 |
human | diseases | 54 |
human | infections | 53 |
positive | outcomes | 53 |
other | cell | 52 |
common | infections | 51 |
different | hospitals | 51 |
early | data | 51 |
low | rates | 51 |
other | hospital | 51 |
first | covid-19 | 50 |
chronic | infections | 50 |
acute | hospital | 49 |
respiratory | care | 49 |
viral | therapy | 49 |
different | diseases | 48 |
higher | age | 48 |
highest | levels | 48 |
such | data | 48 |
such | treatment | 48 |
other | case | 47 |
common | diseases | 47 |
new | blood | 47 |
early | age | 46 |
highest | rate | 46 |
new | infection | 46 |
clinical | analysis | 46 |
acute | disease | 45 |
highest | rates | 45 |
other | outcomes | 45 |
specific | treatments | 45 |
normal | group | 44 |
positive | outcome | 44 |
- | aged | 44 |
clinical | therapies | 44 |
acute | covid-19 | 44 |
first | treatment | 43 |
new | methods | 43 |
new | treatments | 43 |
normal | cells | 43 |
respiratory | rates | 42 |
medical | data | 42 |
early | results | 42 |
- | factors | 42 |
covid-19 | risk | 41 |
covid-19 | treatments | 41 |
positive | covid-19 | 41 |
- | cases | 40 |
- | covid-19 | 40 |
high | patient | 40 |
patients | group | 40 |
positive | rates | 39 |
specific | disease | 39 |
different | factors | 39 |
positive | case | 39 |
medical | treatments | 39 |
different | risk | 38 |
specific | data | 38 |
significant | results | 37 |
normal | patients | 37 |
patient | level | 37 |
severe | case | 37 |
more | risk | 37 |
acute | treatment | 37 |
different | outcomes | 37 |
- | rated | 36 |
early | days | 36 |
early | infection | 36 |
higher | blood | 36 |
different | treatments | 35 |
negative | infections | 35 |
new | infections | 35 |
patient | case | 35 |
medical | therapies | 34 |
such | therapy | 34 |
more | patient | 34 |
chronic | care | 34 |
higher | risks | 34 |
covid-19 | therapies | 34 |
chronic | treatment | 33 |
lower | blood | 33 |
negative | outcomes | 33 |
new | studies | 33 |
more | times | 32 |
other | data | 32 |
acute | sars | 32 |
different | effects | 31 |
- | times | 30 |
chronic | patients | 30 |
human | patients | 30 |
more | years | 30 |
other | age | 30 |
severe | diseases | 30 |
first | blood | 29 |
human | factors | 29 |
significant | level | 29 |
specific | groups | 29 |
high | disease | 28 |
significant | levels | 28 |
severe | outcome | 27 |
respiratory | treatments | 27 |
important | outcomes | 27 |
early | time | 27 |
different | days | 27 |
higher | case | 27 |
different | hospital | 27 |
acute | effects | 26 |
different | ages | 26 |
high | risks | 26 |
lowest | risk | 26 |
significant | disease | 26 |
specific | effects | 26 |
negative | patient | 26 |
early | case | 25 |
normal | cell | 25 |
older | group | 25 |
older | patient | 25 |
specific | case | 25 |
such | treatments | 24 |
specific | cases | 24 |
important | treatment | 24 |
other | infection | 24 |
first | years | 24 |
first | analysis | 24 |
early | therapy | 24 |
common | treatment | 24 |
covid-19 | therapy | 24 |
covid-19 | hospital | 24 |
severe | risk | 23 |
specific | time | 23 |
specific | studies | 23 |
specific | group | 23 |
specific | blood | 23 |
other | sars | 23 |
negative | sars | 23 |
high | infection | 23 |
different | results | 23 |
common | patients | 23 |
acute | patients | 23 |
higher | hospital | 23 |
specific | patients | 22 |
early | hospital | 22 |
such | cells | 22 |
patients | outcome | 22 |
severe | patient | 22 |
- | studied | 22 |
patients | cared | 22 |
high | case | 22 |
- | data | 22 |
covid-19 | case | 21 |
earlier | study | 21 |
early | outcomes | 21 |
first | hospital | 21 |
higher | disease | 21 |
human | data | 21 |
new | therapy | 21 |
patients | results | 21 |
patients | risk | 21 |
such | factors | 21 |
specific | sars | 20 |
patients | care | 20 |
severe | groups | 20 |
non | covid-19 | 20 |
such | study | 20 |
viral | factors | 20 |
older | ages | 20 |
patients | ages | 20 |
important | data | 20 |
- | results | 20 |
- | result | 20 |
higher | infection | 20 |
first | studies | 20 |
common | infection | 20 |
new | covid-19 | 20 |
normal | results | 19 |
viral | treatment | 19 |
specific | risks | 19 |
patients | rated | 19 |
other | time | 19 |
other | covid-19 | 19 |
respiratory | outcomes | 19 |
new | case | 19 |
low | patient | 19 |
human | sars | 19 |
earlier | age | 19 |
first | patients | 19 |
early | cases | 19 |
lowest | level | 19 |
specific | cells | 18 |
viral | cell | 18 |
specific | infections | 18 |
specific | diseases | 18 |
patients | data | 18 |
respiratory | treatment | 18 |
new | risk | 18 |
negative | outcome | 18 |
clinical | infection | 18 |
such | results | 17 |
such | effects | 17 |
specific | methods | 17 |
patient | cases | 17 |
significant | time | 17 |
significant | risks | 17 |
lower | hospital | 17 |
earlier | treatment | 17 |
different | study | 17 |
different | cells | 17 |
common | methods | 17 |
early | study | 17 |
lowest | rate | 16 |
such | diseases | 16 |
such | case | 16 |
significant | blood | 16 |
specific | infection | 16 |
high | treatment | 16 |
first | sars | 16 |
different | outcome | 16 |
- | treatments | 16 |
- | studies | 16 |
negative | cells | 15 |
specific | analysis | 15 |
significant | rate | 15 |
significant | p | 15 |
significant | infection | 15 |
respiratory | patients | 15 |
positive | infections | 15 |
positive | disease | 15 |
other | times | 15 |
other | results | 15 |
acute | cases | 15 |
important | method | 15 |
higher | patient | 15 |
early | risk | 15 |
earlier | time | 15 |
different | therapies | 15 |
different | rates | 15 |
clinical | patient | 15 |
- | rates | 15 |
- | outcome | 15 |
specific | care | 15 |
patients | groups | 14 |
specific | effect | 14 |
patients | resulted | 14 |
patients | methods | 14 |
specific | outcomes | 14 |
such | methods | 14 |
negative | groups | 14 |
normal | day | 14 |
lower | % | 14 |
medical | outcomes | 14 |
low | disease | 14 |
important | disease | 14 |
first | data | 14 |
different | cases | 14 |
common | method | 14 |
acute | blood | 14 |
new | study | 13 |
such | therapies | 13 |
significant | result | 13 |
positive | cell | 13 |
patient | aged | 13 |
other | therapy | 13 |
other | care | 13 |
more | infections | 13 |
important | infection | 13 |
high | cell | 13 |
first | infection | 13 |
clinical | patients | 13 |
chronic | cases | 13 |
acute | hospitals | 13 |
new | hospital | 12 |
more | blood | 12 |
negative | infection | 12 |
new | care | 12 |
respiratory | effects | 12 |
older | studies | 12 |
patients | covid-19 | 12 |
patients | grouped | 12 |
human | factor | 12 |
human | patient | 12 |
viral | effect | 12 |
higher | cell | 12 |
different | level | 12 |
common | hospital | 12 |
common | blood | 12 |
clinical | infections | 12 |
clinical | diseases | 12 |
chronic | therapy | 12 |
chronic | blood | 12 |
- | rating | 12 |
early | covid-19 | 12 |
significant | data | 11 |
patients | outcomes | 11 |
patients | patients | 11 |
patients | sars | 11 |
respiratory | outcome | 11 |
viral | effects | 11 |
significant | infections | 11 |
specific | covid-19 | 11 |
specific | method | 11 |
such | care | 11 |
new | sars | 11 |
viral | studies | 11 |
normal | data | 11 |
other | effects | 11 |
new | cell | 11 |
covid-19 | outcome | 11 |
more | treatment | 11 |
acute | diseases | 11 |
common | cases | 11 |
common | factor | 11 |
covid-19 | hospitals | 11 |
common | group | 11 |
covid-19 | risks | 11 |
different | effect | 11 |
early | group | 11 |
low | infection | 11 |
lower | infection | 11 |
patients | effects | 10 |
new | diseases | 10 |
other | analyses | 10 |
other | risks | 10 |
patient | hospital | 10 |
patient | time | 10 |
medical | patient | 10 |
patients | therapy | 10 |
patients | treatment | 10 |
significant | age | 10 |
significant | group | 10 |
significant | patient | 10 |
such | time | 10 |
negative | covid-19 | 10 |
important | blood | 10 |
lowest | levels | 10 |
early | patients | 10 |
- | outcomes | 10 |
clinical | time | 10 |
clinical | treatments | 10 |
lower | age | 10 |
early | outcome | 10 |
common | patient | 10 |
first | method | 10 |
high | age | 10 |
human | study | 10 |
- | diseases | 10 |
important | effect | 10 |
important | effects | 10 |
old | group | 9 |
patient | disease | 9 |
patient | studies | 9 |
patient | study | 9 |
patients | blood | 9 |
positive | infection | 9 |
such | risk | 9 |
severe | blood | 9 |
severe | treatment | 9 |
specific | outcome | 9 |
specific | results | 9 |
specific | study | 9 |
such | patient | 9 |
new | group | 9 |
normal | times | 9 |
respiratory | risk | 9 |
negative | rates | 9 |
different | group | 9 |
medical | studies | 9 |
chronic | effects | 9 |
clinical | methods | 9 |
clinical | therapy | 9 |
covid-19 | results | 9 |
different | data | 9 |
clinical | level | 9 |
early | infections | 9 |
high | sars | 9 |
higher | treatment | 9 |
important | outcome | 9 |
medical | risk | 9 |
first | result | 9 |
patient | cells | 8 |
more | disease | 8 |
normal | age | 8 |
older | blood | 8 |
pulmonary | outcome | 8 |
patient | infection | 8 |
patient | risks | 8 |
severe | hospital | 8 |
such | risks | 8 |
lower | case | 8 |
medical | disease | 8 |
higher | % | 8 |
low | group | 8 |
different | infections | 8 |
low | factor | 8 |
clinical | hospitals | 8 |
different | case | 8 |
- | timed | 8 |
early | analysis | 8 |
high | group | 8 |
high | hospital | 8 |
important | patient | 8 |
normal | rate | 7 |
old | covid-19 | 7 |
others | studies | 7 |
pulmonary | outcomes | 7 |
patient | results | 7 |
patient | years | 7 |
patients | result | 7 |
positive | treatment | 7 |
new | cells | 7 |
respiratory | data | 7 |
respiratory | therapies | 7 |
significant | rates | 7 |
specific | age | 7 |
specific | hospital | 7 |
such | analysis | 7 |
viral | risk | 7 |
viral | therapies | 7 |
normal | hospital | 7 |
lower | patient | 7 |
negative | cell | 7 |
early | patient | 7 |
more | groups | 7 |
clinical | blood | 7 |
clinical | covid-19 | 7 |
clinical | result | 7 |
covid-19 | diseases | 7 |
different | care | 7 |
earlier | sars | 7 |
clinical | groups | 7 |
first | studied | 7 |
human | case | 7 |
important | group | 7 |
important | studies | 7 |
medical | cases | 7 |
medical | group | 7 |
high | cells | 7 |
patient | covid-19 | 6 |
patients | factors | 6 |
patients | effect | 6 |
patient | year | 6 |
patient | studied | 6 |
normal | result | 6 |
patient | ages | 6 |
older | groups | 6 |
old | disease | 6 |
normal | cases | 6 |
pulmonary | cells | 6 |
positive | groups | 6 |
such | disease | 6 |
respiratory | cells | 6 |
respiratory | study | 6 |
severe | therapy | 6 |
significant | treatment | 6 |
specific | factor | 6 |
specific | level | 6 |
such | analyses | 6 |
newer | methods | 6 |
such | effect | 6 |
such | infection | 6 |
viral | group | 6 |
normal | aging | 6 |
normal | groups | 6 |
new | risks | 6 |
first | disease | 6 |
- | risks | 6 |
new | level | 6 |
clinical | analyses | 6 |
clinical | group | 6 |
clinical | risks | 6 |
covid-19 | care | 6 |
different | method | 6 |
different | risks | 6 |
different | years | 6 |
early | blood | 6 |
early | years | 6 |
- | therapies | 6 |
first | level | 6 |
important | study | 6 |
low | cells | 6 |
lower | cell | 6 |
lower | p | 6 |
medical | factors | 6 |
more | care | 6 |
more | study | 6 |
negative | case | 6 |
negative | studies | 6 |
important | cell | 6 |
other | outcome | 5 |
patients | infection | 5 |
patient | treatments | 5 |
other | studied | 5 |
negative | factor | 5 |
oldest | age | 5 |
normal | treatment | 5 |
normal | patient | 5 |
negative | time | 5 |
patients | resulting | 5 |
patients | rate | 5 |
pulmonary | cell | 5 |
patients | timing | 5 |
positive | risk | 5 |
positive | studies | 5 |
positive | study | 5 |
pulmonary | level | 5 |
pulmonary | patients | 5 |
severe | days | 5 |
specific | rates | 5 |
viral | levels | 5 |
more | hospital | 5 |
negative | disease | 5 |
clinical | method | 5 |
more | factors | 5 |
different | therapy | 5 |
medical | case | 5 |
- | hospitals | 5 |
clinical | hospital | 5 |
clinical | sars | 5 |
common | cell | 5 |
common | factors | 5 |
covid-19 | effects | 5 |
covid-19 | group | 5 |
different | infection | 5 |
common | covid-19 | 5 |
earlier | data | 5 |
first | therapy | 5 |
highest | infection | 5 |
important | diseases | 5 |
important | result | 5 |
important | time | 5 |
low | hospital | 5 |
lower | disease | 5 |
early | sars | 5 |
lower | treatment | 5 |
normal | factor | 4 |
other | factor | 4 |
other | days | 4 |
oldest | patient | 4 |
older | hospital | 4 |
normal | outcome | 4 |
more | results | 4 |
normal | care | 4 |
new | results | 4 |
negative | p | 4 |
more | effect | 4 |
others | patients | 4 |
others | groups | 4 |
such | groups | 4 |
patient | infections | 4 |
patient | resulted | 4 |
patients | caring | 4 |
patients | hospital | 4 |
patients | time | 4 |
severe | level | 4 |
severe | levels | 4 |
specific | day | 4 |
specific | hospitals | 4 |
such | blood | 4 |
such | outcomes | 4 |
lowest | rates | 4 |
more | case | 4 |
positive | p | 4 |
lower | risks | 4 |
different | rate | 4 |
lower | day | 4 |
- | grouped | 4 |
chronic | treatments | 4 |
clinical | levels | 4 |
clinical | year | 4 |
common | age | 4 |
common | outcome | 4 |
- | aging | 4 |
common | treatments | 4 |
covid-19 | levels | 4 |
covid-19 | study | 4 |
different | analysis | 4 |
acute | therapy | 4 |
earlier | disease | 4 |
important | cases | 4 |
low | patients | 4 |
earlier | years | 4 |
low | cell | 4 |
low | case | 4 |
low | p | 4 |
important | care | 4 |
highest | case | 4 |
high | groups | 4 |
first | cell | 4 |
early | methods | 4 |
oldest | patients | 3 |
negative | study | 3 |
older | study | 3 |
normal | time | 3 |
normal | study | 3 |
normal | rates | 3 |
normal | p | 3 |
newer | treatments | 3 |
newer | therapies | 3 |
new | hospitals | 3 |
more | cells | 3 |
negative | studied | 3 |
negative | level | 3 |
negative | hospital | 3 |
more | risks | 3 |
more | methods | 3 |
medical | hospital | 3 |
medical | groups | 3 |
medical | diseases | 3 |
lowest | p | 3 |
low | treatment | 3 |
other | year | 3 |
other | analysis | 3 |
pulmonary | effects | 3 |
other | years | 3 |
others | cases | 3 |
viral | treatments | 3 |
viral | risks | 3 |
viral | factor | 3 |
viral | analysis | 3 |
such | method | 3 |
such | levels | 3 |
significant | outcome | 3 |
significant | hospital | 3 |
significant | cell | 3 |
severest | cases | 3 |
important | treatments | 3 |
pulmonary | cases | 3 |
positive | data | 3 |
patients | study | 3 |
patients | risks | 3 |
patients | case | 3 |
patient | therapy | 3 |
patient | factor | 3 |
patient | day | 3 |
others | risk | 3 |
others | infections | 3 |
low | age | 3 |
newer | studies | 3 |
important | results | 3 |
earliest | cases | 3 |
earlier | methods | 3 |
earlier | infection | 3 |
different | sars | 3 |
different | covid-19 | 3 |
covid-19 | groups | 3 |
covid-19 | factors | 3 |
covid-19 | covid-19 | 3 |
commonest | risk | 3 |
common | therapy | 3 |
common | therapies | 3 |
clinical | rate | 3 |
clinical | factor | 3 |
chronic | time | 3 |
chronic | p | 3 |
acute | therapies | 3 |
acute | study | 3 |
acute | risk | 3 |
acute | patient | 3 |
acute | cell | 3 |
acute | case | 3 |
important | cells | 3 |
earlier | patient | 3 |
common | data | 3 |
earliest | days | 3 |
high | results | 3 |
humans | results | 3 |
earliest | studies | 3 |
human | p | 3 |
human | caring | 3 |
highest | hospital | 3 |
highest | disease | 3 |
highest | age | 3 |
higher | effect | 3 |
higher | day | 3 |
high | time | 3 |
highest | blood | 3 |
high | % | 3 |
first | p | 3 |
first | groups | 3 |
first | cells | 3 |
early | result | 3 |
early | levels | 3 |
early | effects | 3 |
high | effect | 3 |
early | effect | 3 |
earliest | time | 3 |
patient | methods | 2 |
other | levels | 2 |
older | cells | 2 |
older | data | 2 |
oldest | group | 2 |
other | ages | 2 |
patient | cared | 2 |
other | method | 2 |
others | factors | 2 |
patient | analysis | 2 |
patient | effects | 2 |
old | sars | 2 |
old | studies | 2 |
new | analyses | 2 |
old | method | 2 |
old | cells | 2 |
old | cases | 2 |
normal | therapy | 2 |
normal | studies | 2 |
normal | % | 2 |
non | sars | 2 |
newer | treatment | 2 |
more | studied | 2 |
negative | risk | 2 |
negative | factors | 2 |
patient | resulting | 2 |
patient | patients | 2 |
such | age | 2 |
patient | sars | 2 |
patients | days | 2 |
viral | study | 2 |
viral | results | 2 |
such | times | 2 |
such | rates | 2 |
specific | times | 2 |
specific | analyses | 2 |
significant | study | 2 |
significant | sars | 2 |
significant | covid-19 | 2 |
severer | cases | 2 |
severe | risks | 2 |
severe | effects | 2 |
respiratory | times | 2 |
respiratory | time | 2 |
respiratory | sars | 2 |
respiratory | group | 2 |
respiratory | factors | 2 |
respiratory | cell | 2 |
pulmonary | risk | 2 |
pulmonary | levels | 2 |
pulmonary | group | 2 |
pulmonary | effect | 2 |
positives | results | 2 |
patients | infections | 2 |
patients | disease | 2 |
more | treatments | 2 |
new | analysis | 2 |
more | sars | 2 |
early | therapies | 2 |
early | cell | 2 |
early | care | 2 |
earlier | patients | 2 |
earlier | hospital | 2 |
earlier | case | 2 |
earlier | analysis | 2 |
different | day | 2 |
covid-19 | times | 2 |
covid-19 | rates | 2 |
covid-19 | rate | 2 |
covid-19 | methods | 2 |
covid-19 | effect | 2 |
commonest | infections | 2 |
common | effect | 2 |
clinical | age | 2 |
chronic | study | 2 |
chronic | sars | 2 |
chronic | outcome | 2 |
chronic | age | 2 |
acute | time | 2 |
acute | group | 2 |
acute | cares | 2 |
- | resulted | 2 |
- | diseased | 2 |
more | infection | 2 |
early | factor | 2 |
common | effects | 2 |
first | analyses | 2 |
important | hospitals | 2 |
more | group | 2 |
first | care | 2 |
more | factor | 2 |
more | covid-19 | 2 |
more | cell | 2 |
more | analysis | 2 |
medical | study | 2 |
lowest | blood | 2 |
lower | time | 2 |
low | results | 2 |
low | groups | 2 |
important | therapies | 2 |
medical | analysis | 2 |
higher | covid-19 | 2 |
human | covid-19 | 2 |
highest | sars | 2 |
highest | % | 2 |
higher | time | 2 |
first | factor | 2 |
higher | results | 2 |
higher | p | 2 |
high | p | 2 |
high | covid-19 | 2 |
high | care | 2 |
human | therapy | 2 |
oldest | diseases | 1 |
oldest | cases | 1 |
old | groups | 1 |
oldest | treatments | 1 |
older | disease | 1 |
other | aging | 1 |
oldest | ages | 1 |
old | resulting | 1 |
older | datum | 1 |
older | aged | 1 |
old | treatment | 1 |
old | therapies | 1 |
old | methods | 1 |
other | p | 1 |
other | level | 1 |
patient | analyses | 1 |
other | rates | 1 |
others | p | 1 |
old | blood | 1 |
patient | effect | 1 |
patient | diseases | 1 |
patient | cell | 1 |
others | therapies | 1 |
others | studied | 1 |
others | methods | 1 |
other | resulting | 1 |
others | level | 1 |
others | factor | 1 |
others | diseases | 1 |
others | days | 1 |
others | caring | 1 |
others | blood | 1 |
old | data | 1 |
more | therapy | 1 |
normal | sars | 1 |
new | groups | 1 |
more | hospitals | 1 |
more | level | 1 |
more | levels | 1 |
more | result | 1 |
more | therapies | 1 |
patient | rates | 1 |
negative | data | 1 |
negative | day | 1 |
negative | levels | 1 |
negative | therapy | 1 |
negative | treatment | 1 |
negatives | resulting | 1 |
new | age | 1 |
new | factor | 1 |
new | levels | 1 |
normal | risk | 1 |
new | outcome | 1 |
new | outcomes | 1 |
newer | data | 1 |
newer | hospital | 1 |
newer | method | 1 |
newest | sars | 1 |
newest | treatment | 1 |
non | age | 1 |
non | blood | 1 |
non | groups | 1 |
non | patient | 1 |
normal | diseases | 1 |
normal | infection | 1 |
normal | infections | 1 |
patient | levels | 1 |
respiratory | patient | 1 |
patient | times | 1 |
specific | % | 1 |
specifics | factors | 1 |
specific | result | 1 |
specific | rate | 1 |
specific | p | 1 |
specific | levels | 1 |
specific | days | 1 |
significant | year | 1 |
severe | result | 1 |
significant | studies | 1 |
significant | day | 1 |
significant | cases | 1 |
significant | case | 1 |
significant | care | 1 |
severe | time | 1 |
such | cell | 1 |
such | covid-19 | 1 |
such | factor | 1 |
such | group | 1 |
such | hospital | 1 |
such | hospitals | 1 |
such | outcome | 1 |
such | sars | 1 |
such | year | 1 |
viral | cases | 1 |
viral | data | 1 |
viral | groups | 1 |
viral | level | 1 |
viral | method | 1 |
viral | patients | 1 |
viral | result | 1 |
viral | sars | 1 |
severe | studies | 1 |
severe | rate | 1 |
patients | % | 1 |
patients | patient | 1 |
positive | levels | 1 |
positive | factors | 1 |
positive | diseases | 1 |
patients | years | 1 |
patients | year | 1 |
patients | rates | 1 |
patients | p | 1 |
severe | p | 1 |
patients | method | 1 |
patients | levels | 1 |
patients | level | 1 |
patients | factor | 1 |
patients | diseases | 1 |
patients | aging | 1 |
positive | therapy | 1 |
pulmonary | covid-19 | 1 |
pulmonary | factors | 1 |
pulmonary | p | 1 |
pulmonary | risks | 1 |
pulmonary | therapies | 1 |
pulmonary | time | 1 |
respiratory | cases | 1 |
respiratory | factor | 1 |
respiratory | hospital | 1 |
respiratory | levels | 1 |
more | analyses | 1 |
respiratory | risks | 1 |
respiratory | studies | 1 |
severe | age | 1 |
severe | day | 1 |
severe | factor | 1 |
more | diseases | 1 |
low | time | 1 |
more | age | 1 |
different | cares | 1 |
earlier | analyses | 1 |
differents | times | 1 |
differents | levels | 1 |
different | timed | 1 |
different | studys | 1 |
different | p | 1 |
different | analyses | 1 |
early | times | 1 |
different | aging | 1 |
covid-19 | years | 1 |
covid-19 | studies | 1 |
covid-19 | resulting | 1 |
covid-19 | level | 1 |
covid-19 | days | 1 |
earlier | day | 1 |
earlier | days | 1 |
earlier | results | 1 |
earlier | therapy | 1 |
earlier | times | 1 |
earliest | day | 1 |
earliest | disease | 1 |
earliest | effects | 1 |
earliest | infection | 1 |
earliest | methods | 1 |
earliest | patients | 1 |
earliest | sars | 1 |
earliest | year | 1 |
early | analyses | 1 |
early | factors | 1 |
early | level | 1 |
early | rate | 1 |
covid-19 | day | 1 |
commonest | treatment | 1 |
commonest | infection | 1 |
chronic | studies | 1 |
- | caring | 1 |
- | casing | 1 |
- | grouping | 1 |
- | resulting | 1 |
- | risked | 1 |
acute | data | 1 |
acute | effect | 1 |
acute | outcome | 1 |
acute | risks | 1 |
acute | studies | 1 |
acute | treatments | 1 |
chronic | cell | 1 |
chronic | hospital | 1 |
chronic | risk | 1 |
chronic | therapies | 1 |
commonest | hospital | 1 |
clinical | years | 1 |
common | analyses | 1 |
common | care | 1 |
common | case | 1 |
common | cells | 1 |
common | groups | 1 |
common | p | 1 |
common | result | 1 |
common | results | 1 |
common | risks | 1 |
common | study | 1 |
common | time | 1 |
commonest | blood | 1 |
commonest | disease | 1 |
early | rates | 1 |
early | treatments | 1 |
medical | outcome | 1 |
lower | effect | 1 |
lower | times | 1 |
lower | sars | 1 |
lower | results | 1 |
lower | outcome | 1 |
lower | groups | 1 |
lower | effects | 1 |
lower | covid-19 | 1 |
first | age | 1 |
low | sars | 1 |
low | risks | 1 |
low | result | 1 |
low | effect | 1 |
low | covid-19 | 1 |
low | % | 1 |
lowest | age | 1 |
lowest | case | 1 |
lowest | cell | 1 |
lowest | effects | 1 |
lowest | results | 1 |
lowest | study | 1 |
medical | age | 1 |
medical | analyses | 1 |
medical | blood | 1 |
medical | cares | 1 |
medical | covid-19 | 1 |
medical | day | 1 |
medical | effect | 1 |
medical | effects | 1 |
medical | infection | 1 |
medical | infections | 1 |
medical | methods | 1 |
important | therapy | 1 |
important | risks | 1 |
important | rate | 1 |
highest | cases | 1 |
first | ages | 1 |
first | infections | 1 |
first | outcome | 1 |
first | resulted | 1 |
first | risk | 1 |
first | times | 1 |
high | cases | 1 |
high | day | 1 |
high | factor | 1 |
high | patients | 1 |
high | risked | 1 |
higher | effects | 1 |
higher | factor | 1 |
higher | therapy | 1 |
highest | cell | 1 |
important | patients | 1 |
highest | rated | 1 |
highest | time | 1 |
human | age | 1 |
human | group | 1 |
human | results | 1 |
human | time | 1 |
human | treatment | 1 |
humans | resulted | 1 |
humans | risk | 1 |
humans | studies | 1 |
important | day | 1 |
important | infections | 1 |
important | level | 1 |
important | methods | 1 |
viral | time | 1 |